Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1984 4
1985 1
1986 3
1987 5
1988 3
1990 6
1991 4
1992 8
1993 4
1994 2
1995 3
1998 4
1999 1
2017 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment.
Seckinger A, Delgado JA, Moser S, Moreno L, Neuber B, Grab A, Lipp S, Merino J, Prosper F, Emde M, Delon C, Latzko M, Gianotti R, Lüoend R, Murr R, Hosse RJ, Harnisch LJ, Bacac M, Fauti T, Klein C, Zabaleta A, Hillengass J, Cavalcanti-Adam EA, Ho AD, Hundemer M, San Miguel JF, Strein K, Umaña P, Hose D, Paiva B, Vu MD. Seckinger A, et al. Among authors: strein k. Cancer Cell. 2017 Mar 13;31(3):396-410. doi: 10.1016/j.ccell.2017.02.002. Epub 2017 Mar 2. Cancer Cell. 2017. PMID: 28262554 Free article.
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.
Seckinger A, Majocchi S, Moine V, Nouveau L, Ngoc H, Daubeuf B, Ravn U, Pleche N, Calloud S, Broyer L, Cons L, Lesnier A, Chatel L, Papaioannou A, Salgado-Pires S, Krämer S, Gockel I, Lordick F, Masternak K, Poitevin Y, Magistrelli G, Malinge P, Shang L, Kallendrusch S, Strein K, Hose D. Seckinger A, et al. Among authors: strein k. J Hematol Oncol. 2023 Dec 12;16(1):117. doi: 10.1186/s13045-023-01516-3. J Hematol Oncol. 2023. PMID: 38087365 Free PMC article.
Vasodilatory action of carvedilol.
Sponer G, Strein K, Bartsch W, Müller-Beckmann B. Sponer G, et al. Among authors: strein k. J Cardiovasc Pharmacol. 1992;19 Suppl 1:S5-11. doi: 10.1097/00005344-199219001-00003. J Cardiovasc Pharmacol. 1992. PMID: 1378150 Review.
Pharmacological characteristics of the stereoisomers of carvedilol.
Bartsch W, Sponer G, Strein K, Müller-Beckmann B, Kling L, Böhm E, Martin U, Borbe HO. Bartsch W, et al. Among authors: strein k. Eur J Clin Pharmacol. 1990;38 Suppl 2:S104-7. doi: 10.1007/BF01409475. Eur J Clin Pharmacol. 1990. PMID: 1974497
BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
Mühlbauer RC, Bauss F, Schenk R, Janner M, Bosies E, Strein K, Fleisch H. Mühlbauer RC, et al. Among authors: strein k. J Bone Miner Res. 1991 Sep;6(9):1003-11. doi: 10.1002/jbmr.5650060915. J Bone Miner Res. 1991. PMID: 1838661 Free article.
52 results